Both animal models of experimental myocardial infarction and clinical studies on reperfusion
therapy for acute myocardial infarction have provided evidence of impaired tissue perfusion …

Background—No-reflow after reperfusion therapy for myocardial infarction is a strong
predictor of clinical outcome. But its fate on a long-term basis and potential significance for …

The no-reflow phenomenon refers to the observation that when an organ is made ischemic
by occlusion of a large artery supplying it, restoration of patency in that artery does not …

To try to unravel the complexity and heterogeneity of the" no-reflow" phenomenon and its
underlying mechanisms, we studied tissue perfusion in reperfused heart muscle by using …

No reflow after acute myocardial infarction is an important predictor of infarct size and
clinical outcome. However, the exact relationship between no reflow and infarct size remains …

The no-reflow phenomenon relates to the inability to reperfuse regions of the myocardium
after ischemia, despite removal of the large epicardial coronary artery occlusion. The …

During reperfusion of a myocardial infarct, development of microvascular occlusion may
result in regional hypoperfusion (“no reflow”) despite a patent infarct-related artery. This …

The rapid restoration of coronary flow to the jeopardized myocardium has become an
essential part of therapy after acute myocardial infarction. Despite an open infarct-related …

The aim was to define the degree and time course of reperfusion-related expansion of no
reflow. In five groups of anesthetized, open-chest rabbits (30-min coronary occlusion and …

Objective: To identify in humans the temporal patterns of no reflow and their functional
implications. Methods: 24 patients with first acute myocardial infarction and successful …